Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-521 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-36 Reduced 6.46%
521 $2,000
Q2 2021

Aug 16, 2021

SELL
N/A
-179 Reduced 24.32%
557 $3,000
Q1 2021

May 13, 2021

SELL
N/A
-28,510 Reduced 97.48%
736 $3,000
Q4 2020

Feb 09, 2021

SELL
N/A
-1,330 Reduced 4.35%
29,246 $127,000
Q3 2020

Nov 05, 2020

SELL
N/A
-1,333 Reduced 4.18%
30,576 $126,000
Q2 2020

Aug 13, 2020

SELL
N/A
-17,775 Reduced 35.78%
31,909 $81,000
Q1 2020

May 14, 2020

BUY
N/A
49,684 New
49,684 $144,000

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.